A clinical study published in the September 2020 issue of the Journal of Glaucoma reported on the safety and efficacy at 2 years of the Aurolab Aqueous Drainage Implant (AADI).
The AADI is a non-valved glaucoma shunt indicated for glaucoma patients who are not responding to medical therapy, failed trabeculectomy, neo-vascular, congenital and uveitic glaucoma.
This low cost non-valved 350mm² glaucoma shunt is now available in New Zealand exclusively through Medix 21 for $250 (+ GST).
Contact Camille on camille@medix21.co.nz or 021 734 762 for more details.
You can read the full article here.
https://journals.lww.com/glaucomajournal/Abstract/2020/09000/Two_Year_Outcomes_of_the_New_Low_cost_Nonvalved.8.aspx
